Health and wellness advice, facts, and tips for living a well-balanced and comfortable lifestyle.

GLP-1

GLP-1 Agonists: Making the Informed Choice

Curious about the science behind today’s most talked-about diabetes and weight-management treatments? Our new, four-part blog series on GLP-1 Agonists will break down everything you need to know — from how these drugs work, to their real-world results, side effects, and what’s coming next in the pipeline. Today, we’re covering how someone might choose between GLP-1 molecules,

GLP-1 agonist

GLP-1 Agonists: What They Are & What Makes Them Unique

Curious about the science behind today’s most talked-about diabetes and weight-management treatments? Our new, four-part blog series on GLP-1 Agonists will break down everything you need to know — from how these drugs work, to their real-world results, side effects, and what’s coming next in the pipeline.   GLP-1 stands for glucagon-like peptide-1. It’s an incretin

BMI Calculator, obesity, fecal microbiota transplant benefits

A Single Fecal Transplant Shows Lasting Health Benefits in Teens

A groundbreaking study from the University of Auckland has found that a single fecal microbiota transplant (FMT) can provide obese teenagers with years of health benefits. FMT involves transferring gut bacteria from healthy donors to patients—in this case, through capsules swallowed over two days. While the idea may sound unappealing, the results are remarkable. The

oral weight loss drug

Lilly’s Oral Weight Loss Drug Shows Strong Results in Diabetes Patients

Eli Lilly is moving closer to bringing its experimental weight loss pill, orforglipron, to market after releasing positive results from its latest phase 3 clinical trial. The study, called Attain-2, tested the once-daily pill in people who are overweight or obese and also have Type 2 diabetes—a group often harder to treat. The trial found

Pfizer pediatric COVID vaccine EUA

FDA May Limit Pfizer’s Pediatric COVID Vaccine Authorization, Raising Concerns for Fall Immunizations

The availability of COVID-19 vaccines for young children in the U.S. could shrink this fall as the Food and Drug Administration (FDA) considers ending the emergency use authorization (EUA) for Pfizer-BioNTech’s vaccine in kids ages 6 months to 4 years. Pfizer says it is in discussions with the FDA and has asked to keep the

Alzheimer disease hereditary

New Dosing for Lilly Alzheimer’s Drug Shows Safer Profile

The FDA has approved a safer dosing schedule for Eli Lilly’s Alzheimer’s drug, Kisunla, which could make it more appealing to doctors and patients. The updated schedule reduces the risk of a serious side effect called ARIA-E—brain swelling caused by anti-amyloid drugs. Originally, Kisunla was given in higher doses early on. Now, the drug will